Anticoagulants Drug Market, Global Outlook and Forecast 2022-2028
Report Code: KNJ1281650 No. of Pages: 77 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
This report contains market size and forecasts of Anticoagulants Drug in global, including the following market information:
Global Anticoagulants Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Anticoagulants Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Anticoagulants Drug companies in 2021 (%)
The global Anticoagulants Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Novel Oral Anticoagulants (NOACs) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anticoagulants Drug include C. H. Boehringer Sohn (Germany), Bristol-Myers Squibb (US), Johnson & Johnson (US), Pfizer (US), Daiichi Sankyo (Japan), Portola Pharmaceuticals (US), Roche (Switzerland), Abbott (US) and Siemens (Germany), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anticoagulants Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anticoagulants Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Anticoagulants Drug Market Segment Percentages, by Type, 2021 (%)
Novel Oral Anticoagulants (NOACs)
Warfarin (VKA)
Others
Global Anticoagulants Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Anticoagulants Drug Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Anticoagulants Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Anticoagulants Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anticoagulants Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Anticoagulants Drug revenues share in global market, 2021 (%)
Key companies Anticoagulants Drug sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Anticoagulants Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
C. H. Boehringer Sohn (Germany)
Bristol-Myers Squibb (US)
Johnson & Johnson (US)
Pfizer (US)
Daiichi Sankyo (Japan)
Portola Pharmaceuticals (US)
Roche (Switzerland)
Abbott (US)
Siemens (Germany)
Alere (US)
CoaguSense (US)
1 Introduction to Research & Analysis Reports
1.1 Anticoagulants Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anticoagulants Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anticoagulants Drug Overall Market Size
2.1 Global Anticoagulants Drug Market Size: 2021 VS 2028
2.2 Global Anticoagulants Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Anticoagulants Drug Sales: 2017-2028
3 Company Landscape
3.1 Top Anticoagulants Drug Players in Global Market
3.2 Top Global Anticoagulants Drug Companies Ranked by Revenue
3.3 Global Anticoagulants Drug Revenue by Companies
3.4 Global Anticoagulants Drug Sales by Companies
3.5 Global Anticoagulants Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Anticoagulants Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Anticoagulants Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anticoagulants Drug Players in Global Market
3.8.1 List of Global Tier 1 Anticoagulants Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Anticoagulants Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anticoagulants Drug Market Size Markets, 2021 & 2028
4.1.2 Novel Oral Anticoagulants (NOACs)
4.1.3 Warfarin (VKA)
4.1.4 Others
4.2 By Type - Global Anticoagulants Drug Revenue & Forecasts
4.2.1 By Type - Global Anticoagulants Drug Revenue, 2017-2022
4.2.2 By Type - Global Anticoagulants Drug Revenue, 2023-2028
4.2.3 By Type - Global Anticoagulants Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Anticoagulants Drug Sales & Forecasts
4.3.1 By Type - Global Anticoagulants Drug Sales, 2017-2022
4.3.2 By Type - Global Anticoagulants Drug Sales, 2023-2028
4.3.3 By Type - Global Anticoagulants Drug Sales Market Share, 2017-2028
4.4 By Type - Global Anticoagulants Drug Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Anticoagulants Drug Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Anticoagulants Drug Revenue & Forecasts
5.2.1 By Application - Global Anticoagulants Drug Revenue, 2017-2022
5.2.2 By Application - Global Anticoagulants Drug Revenue, 2023-2028
5.2.3 By Application - Global Anticoagulants Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Anticoagulants Drug Sales & Forecasts
5.3.1 By Application - Global Anticoagulants Drug Sales, 2017-2022
5.3.2 By Application - Global Anticoagulants Drug Sales, 2023-2028
5.3.3 By Application - Global Anticoagulants Drug Sales Market Share, 2017-2028
5.4 By Application - Global Anticoagulants Drug Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Anticoagulants Drug Market Size, 2021 & 2028
6.2 By Region - Global Anticoagulants Drug Revenue & Forecasts
6.2.1 By Region - Global Anticoagulants Drug Revenue, 2017-2022
6.2.2 By Region - Global Anticoagulants Drug Revenue, 2023-2028
6.2.3 By Region - Global Anticoagulants Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Anticoagulants Drug Sales & Forecasts
6.3.1 By Region - Global Anticoagulants Drug Sales, 2017-2022
6.3.2 By Region - Global Anticoagulants Drug Sales, 2023-2028
6.3.3 By Region - Global Anticoagulants Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Anticoagulants Drug Revenue, 2017-2028
6.4.2 By Country - North America Anticoagulants Drug Sales, 2017-2028
6.4.3 US Anticoagulants Drug Market Size, 2017-2028
6.4.4 Canada Anticoagulants Drug Market Size, 2017-2028
6.4.5 Mexico Anticoagulants Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Anticoagulants Drug Revenue, 2017-2028
6.5.2 By Country - Europe Anticoagulants Drug Sales, 2017-2028
6.5.3 Germany Anticoagulants Drug Market Size, 2017-2028
6.5.4 France Anticoagulants Drug Market Size, 2017-2028
6.5.5 U.K. Anticoagulants Drug Market Size, 2017-2028
6.5.6 Italy Anticoagulants Drug Market Size, 2017-2028
6.5.7 Russia Anticoagulants Drug Market Size, 2017-2028
6.5.8 Nordic Countries Anticoagulants Drug Market Size, 2017-2028
6.5.9 Benelux Anticoagulants Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Anticoagulants Drug Revenue, 2017-2028
6.6.2 By Region - Asia Anticoagulants Drug Sales, 2017-2028
6.6.3 China Anticoagulants Drug Market Size, 2017-2028
6.6.4 Japan Anticoagulants Drug Market Size, 2017-2028
6.6.5 South Korea Anticoagulants Drug Market Size, 2017-2028
6.6.6 Southeast Asia Anticoagulants Drug Market Size, 2017-2028
6.6.7 India Anticoagulants Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Anticoagulants Drug Revenue, 2017-2028
6.7.2 By Country - South America Anticoagulants Drug Sales, 2017-2028
6.7.3 Brazil Anticoagulants Drug Market Size, 2017-2028
6.7.4 Argentina Anticoagulants Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anticoagulants Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Anticoagulants Drug Sales, 2017-2028
6.8.3 Turkey Anticoagulants Drug Market Size, 2017-2028
6.8.4 Israel Anticoagulants Drug Market Size, 2017-2028
6.8.5 Saudi Arabia Anticoagulants Drug Market Size, 2017-2028
6.8.6 UAE Anticoagulants Drug Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 C. H. Boehringer Sohn (Germany)
7.1.1 C. H. Boehringer Sohn (Germany) Corporate Summary
7.1.2 C. H. Boehringer Sohn (Germany) Business Overview
7.1.3 C. H. Boehringer Sohn (Germany) Anticoagulants Drug Major Product Offerings
7.1.4 C. H. Boehringer Sohn (Germany) Anticoagulants Drug Sales and Revenue in Global (2017-2022)
7.1.5 C. H. Boehringer Sohn (Germany) Key News
7.2 Bristol-Myers Squibb (US)
7.2.1 Bristol-Myers Squibb (US) Corporate Summary
7.2.2 Bristol-Myers Squibb (US) Business Overview
7.2.3 Bristol-Myers Squibb (US) Anticoagulants Drug Major Product Offerings
7.2.4 Bristol-Myers Squibb (US) Anticoagulants Drug Sales and Revenue in Global (2017-2022)
7.2.5 Bristol-Myers Squibb (US) Key News
7.3 Johnson & Johnson (US)
7.3.1 Johnson & Johnson (US) Corporate Summary
7.3.2 Johnson & Johnson (US) Business Overview
7.3.3 Johnson & Johnson (US) Anticoagulants Drug Major Product Offerings
7.3.4 Johnson & Johnson (US) Anticoagulants Drug Sales and Revenue in Global (2017-2022)
7.3.5 Johnson & Johnson (US) Key News
7.4 Pfizer (US)
7.4.1 Pfizer (US) Corporate Summary
7.4.2 Pfizer (US) Business Overview
7.4.3 Pfizer (US) Anticoagulants Drug Major Product Offerings
7.4.4 Pfizer (US) Anticoagulants Drug Sales and Revenue in Global (2017-2022)
7.4.5 Pfizer (US) Key News
7.5 Daiichi Sankyo (Japan)
7.5.1 Daiichi Sankyo (Japan) Corporate Summary
7.5.2 Daiichi Sankyo (Japan) Business Overview
7.5.3 Daiichi Sankyo (Japan) Anticoagulants Drug Major Product Offerings
7.5.4 Daiichi Sankyo (Japan) Anticoagulants Drug Sales and Revenue in Global (2017-2022)
7.5.5 Daiichi Sankyo (Japan) Key News
7.6 Portola Pharmaceuticals (US)
7.6.1 Portola Pharmaceuticals (US) Corporate Summary
7.6.2 Portola Pharmaceuticals (US) Business Overview
7.6.3 Portola Pharmaceuticals (US) Anticoagulants Drug Major Product Offerings
7.6.4 Portola Pharmaceuticals (US) Anticoagulants Drug Sales and Revenue in Global (2017-2022)
7.6.5 Portola Pharmaceuticals (US) Key News
7.7 Roche (Switzerland)
7.7.1 Roche (Switzerland) Corporate Summary
7.7.2 Roche (Switzerland) Business Overview
7.7.3 Roche (Switzerland) Anticoagulants Drug Major Product Offerings
7.7.4 Roche (Switzerland) Anticoagulants Drug Sales and Revenue in Global (2017-2022)
7.7.5 Roche (Switzerland) Key News
7.8 Abbott (US)
7.8.1 Abbott (US) Corporate Summary
7.8.2 Abbott (US) Business Overview
7.8.3 Abbott (US) Anticoagulants Drug Major Product Offerings
7.8.4 Abbott (US) Anticoagulants Drug Sales and Revenue in Global (2017-2022)
7.8.5 Abbott (US) Key News
7.9 Siemens (Germany)
7.9.1 Siemens (Germany) Corporate Summary
7.9.2 Siemens (Germany) Business Overview
7.9.3 Siemens (Germany) Anticoagulants Drug Major Product Offerings
7.9.4 Siemens (Germany) Anticoagulants Drug Sales and Revenue in Global (2017-2022)
7.9.5 Siemens (Germany) Key News
7.10 Alere (US)
7.10.1 Alere (US) Corporate Summary
7.10.2 Alere (US) Business Overview
7.10.3 Alere (US) Anticoagulants Drug Major Product Offerings
7.10.4 Alere (US) Anticoagulants Drug Sales and Revenue in Global (2017-2022)
7.10.5 Alere (US) Key News
7.11 CoaguSense (US)
7.11.1 CoaguSense (US) Corporate Summary
7.11.2 CoaguSense (US) Anticoagulants Drug Business Overview
7.11.3 CoaguSense (US) Anticoagulants Drug Major Product Offerings
7.11.4 CoaguSense (US) Anticoagulants Drug Sales and Revenue in Global (2017-2022)
7.11.5 CoaguSense (US) Key News
8 Global Anticoagulants Drug Production Capacity, Analysis
8.1 Global Anticoagulants Drug Production Capacity, 2017-2028
8.2 Anticoagulants Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Anticoagulants Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anticoagulants Drug Supply Chain Analysis
10.1 Anticoagulants Drug Industry Value Chain
10.2 Anticoagulants Drug Upstream Market
10.3 Anticoagulants Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anticoagulants Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com